eFFECTOR Therapeutics
(OTC) EFTR
eFFECTOR Therapeutics Financials at a Glance
Market Cap
$900
Revenue (TTM)
$162.00K
Net Income (TTM)
$34.63M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-15.84 (Low)
Dividend
$0.00
Beta (Volatility)
-15.84 (Low)
Price
$0.00
Volume
16
Open
$0.00
Price
$0.00
Volume
16
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Dividend
$0.00
Beta (Volatility)
-15.84 (Low)
Price
$0.00
Volume
16
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
EFTR News
EFTR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout eFFECTOR Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Stephen T. Worland, PhD
Website
www.effector.comHeadquarters
Solana Beach, CA 92075, US
EFTR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
6%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$900.00
Shares Outstanding
4.70M
Volume
16
Short Interest
0.00%
Avg. Volume
3.26K
Financials (TTM)
Gross Profit
$111.00K
Operating Income
$33.84M
EBITDA
$32.78M
Operating Cash Flow
$29.55M
Capital Expenditure
$97.00K
Free Cash Flow
$29.65M
Cash & ST Invst.
$18.37M
Total Debt
$20.55M
eFFECTOR Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$28.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$900.00
N/A
Market Cap/Employee
$64.29
N/A
Employees
14
N/A
Net Income
$8.83M
+11.8%
EBITDA
$8.06M
+13.3%
Quarterly Fundamentals
Net Cash
$5.13M
+483.5%
Accounts Receivable
$17.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$179.00K
+316.3%
Short Term Debt
$20.07M
-1.2%
Return on Assets
-1.74%
N/A
Return on Invested Capital
6.44%
N/A
Free Cash Flow
$7.28M
+4.9%
Operating Cash Flow
$7.28M
+4.7%